Confidential Treatment Requested by Maplebear Inc.
Pursuant to 17 C.F.R. Section 200.83
July 2018 Retailer Warrants
In July 2018, the Company entered into a warrant agreement with another retailer to issue warrants for the purchase of up to 14,863,040 shares of non-voting common stock with an exercise price of $18.52. The warrants vest subject to achievement of time-based milestones. Vesting commenced on January 1, 2018, the vesting start date, with 3,715,760 shares each vesting on the 12 and 24-month anniversaries of the vesting commencement date and four tranches of 1,857,880 shares each vesting every six months thereafter. The retailer can exercise any or all shares vested for a given milestone on or within 90 days following the date of the milestone being achieved. These warrants expire the earliest of 90 days subsequent to the 48-month anniversary of the warrant agreement, a Deemed Liquidation Event (as defined in Note 11 – Redeemable Convertible Preferred Stock), or the date the warrant is no longer eligible to be exercised or vest with respect to any shares.
During the years ended December 31, 2019, 2020, and 2021, 3,715,760, 5,573,640, and 3,715,760 warrants vested, respectively. During the years ended December 31, 2020 and 2021, the retailer exercised warrants to purchase 1,857,880 and 3,715,760 shares of non-voting common stock, respectively, at a price of $18.52 per share, with total proceeds of $34 million and $68 million, respectively. During the years ended December 31, 2019, 2020, and 2021, 3,715,760, 3,715,760 and zero fully vested warrants expired unexercised, respectively. As of December 31, 2020 and 2021, 5,573,640 and 1,857,880 warrants were outstanding and unvested, respectively. The weighted-average remaining contractual term as of December 31, 2021 of the warrants outstanding was 0.25 years. The aggregate intrinsic value as of December 31, 2021 of the warrants outstanding was $163 million.
July 2018 Retailer Subscription Agreement
In July 2018, in conjunction with the warrant agreement with the same retailer, the Company also entered into a subscription agreement that provided for the issuance of 3,715,760 shares of non-voting common stock for no cash consideration. The shares issuable pursuant to the subscription agreement vest upon four time-based milestones, subject to continued compliance with the commercial agreement. Vesting commenced on January 1, 2018, the vesting start date, with 1,393,410 shares vesting on the 12 and 24-month anniversary, and 464,470 shares vesting on the 36 and 48-month anniversary of the vesting start date.
During the years ended December 31, 2019, 2020, and 2021, 1,393,410, 1,393,410, and 464,470 shares vested and were issued, respectively. None of the shares issuable pursuant to the subscription agreement were canceled during the years ended December 31, 2019, 2020, or 2021. As of December 31, 2020 and 2021, 928,940 and 464,470 shares issuable pursuant to the subscription agreement were outstanding and unvested, respectively. The fair value per share as of December 31, 2020 and 2021 was $47.69 and $106.08, respectively. The weighted-average remaining contractual term as of December 31, 2021 of shares outstanding was 0.00 years. The aggregate intrinsic value of shares outstanding as of December 31, 2021 was $49 million.
During the year ended December 31, 2021, the Company issued non-voting common stock to certain retailers. Refer to Note 12 –Stockholders’ Deficit for further discussion.
Former Retailer
In 2016, the Company received a one-time payment of $4 million and issued 1,540,640 shares of Series B redeemable convertible preferred stock at a price of $2.98 per share, for an aggregate purchase price of $5 million in connection with a commercial agreement with a retailer. In addition, the Company issued warrants for the retailer to purchase 2,695,810 shares of Series C redeemable convertible preferred stock at an exercise price of $13.31 per share. These warrants vested on the achievement of certain performance targets.
In 2018, in conjunction with an agreement to end the commercial relationship with the Company effective mid-2019, the retailer paid $8 million of cash consideration to the Company, sold the previously purchased Series B redeemable convertible preferred stock back to the Company for $2 million, and surrendered to the Company previously granted Series C redeemable convertible preferred stock warrants. The cash received and fair value in excess of consideration paid for the Series B redeemable convertible preferred stock of $22 million and Series C redeemable convertible preferred stock warrants of $8 million, respectively, were recognized as additional
F-27